[Cardiomyopathy and inborn errors of metabolism in children. Study of 12 cases]

Med Clin (Barc). 2011 Nov 19;137(13):596-9. doi: 10.1016/j.medcli.2011.06.019. Epub 2011 Sep 28.
[Article in Spanish]

Abstract

Background and objective: Cardiomyopathy in childhood is a rare entity. Inborn errors of metabolism can cause myocardial involvement by several mechanisms.

Patients and methods: Patients under 16 years diagnosed with cardiomyopathy and EIM in a period of 11 years (1998-2009) were included.

Results: A total of 12 patients were studied (8% of all cardiomyopathies), 9 boys and three girls, with a median age at diagnosis of 6 months (range: birth-8.8 years). Fifty percent had an onset with cardiac symptoms and heart failure was associated with an earlier diagnosis of the disease (P<.05). On ultrasound 10 patients had ventricular hypertrophy, which was associated with mitochondrial and lysosomal disease; only 2 patients had ventricular dilatation, which was associated with altered fatty acid metabolism (P<.05). The median survival was 5 months (range: 2-11 months). No variable was significantly associated with the likelihood of death.

Conclusions: Patients with heart failure at onset are diagnosed earlier (before 3 months of life). Echocardiography helps in the diagnosis and monitoring of metabolic disease.

Publication types

  • English Abstract

MeSH terms

  • Age Factors
  • Cardiomyopathies / diagnosis
  • Cardiomyopathies / etiology*
  • Cardiomyopathies / mortality
  • Cardiomyopathies / therapy
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Kaplan-Meier Estimate
  • Male
  • Metabolism, Inborn Errors / complications*
  • Metabolism, Inborn Errors / diagnosis
  • Metabolism, Inborn Errors / mortality
  • Metabolism, Inborn Errors / therapy
  • Retrospective Studies